Results 241 to 250 of about 746,598 (344)

Non-invasive pressure support ventilation and CPAP in cardiogenic pulmonary edema: a multicenter randomized study in the emergency department

Intensive Care Medicine, 2011
S. Nouira, R. Boukef, W. Bouida, W. Kerkeni, Kaouther Beltaief, Hamdi Boubaker, Latifa Boudhib, M. Grissa, M. N. Trimech, Hamadi Boussarsar, M. Methamem, S. Marghli, Mondher Ltaief   +12 more
semanticscholar   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Role of Helmet-Delivered Noninvasive Pressure Support Ventilation in COVID-19 Patients. [PDF]

J Cardiothorac Vasc Anesth, 2020
Ing RJ, Bills C, Merritt G, Ragusa R, Bremner RM, Bellia F.   +5 more
europepmc   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

Successful Versus Failed Transition From Controlled Ventilation to Pressure Support Ventilation in COVID-19 Patients: A Retrospective Cohort Study. [PDF]

Crit Care Explor
Polo Friz M, Rezoagli E, Safaee Fakhr B, Florio G, Carlesso E, Giudici R, Forlini C, Tardini F, Langer T, Laratta M, Casella G, Forastieri Molinari A, Protti A, Cecconi M, Cabrini L, Biagioni E, Berselli A, Mirabella L, Tonetti T, De Robertis E, Grieco DL, Antonelli M, Citerio G, Fumagalli R, Foti G, Zanella A, Grasselli G, Bellani G.   +27 more
europepmc   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Inferior vena cava distensibility during pressure support ventilation: a prospective study evaluating interchangeability of subcostal and trans‑hepatic views, with both M‑mode and automatic border tracing. [PDF]

J Clin Monit Comput
Zawadka M, Santonocito C, Dezio V, Amelio P, Messina S, Cardia L, Franchi F, Messina A, Robba C, Noto A, Sanfilippo F.   +10 more
europepmc   +1 more source

Pressure support versus T-tube for weaning from mechanical ventilation in adults.

Cochrane Database of Systematic Reviews, 2014
Magdaline T Ladeira, Flávia M R Vital, R. Andriolo, Brenda N G Andriolo, Á. Atallah, M. Peccin   +5 more
semanticscholar   +1 more source

Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients

British Journal of Clinical Pharmacology, EarlyView.
Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel, Christine van Linge, W. Joost Wiersinga, Ilse J. E. Kouijzer, Quirijn de Mast, Robert‐Jan Hassing, Danique J. H. Huijbens, Helen L. Leavis, Roger Schutgens, Coen Maas, Kit C. B. Roes, Frank L. van de Veerdonk, Roger Brüggemann   +12 more
wiley   +1 more source

The level of partial pressure of carbon dioxide affects respiratory effort in COVID-19 patients undergoing pressure support ventilation with extracorporeal membrane oxygenation. [PDF]

BMC Anesthesiol
Zhou Y, Wang X, Du W, He H, Wang X, Cui N, Long Y.   +6 more
europepmc   +1 more source